The Economics of Healthcare- Blood Cancer

[otonal]

This popped up on Twitter as a sponsored link. It's worth reading

janssen-emea.com/sites/defa...

[AussieNeil Partner Administrator]

Excellent points - surely policy makers need to know the TOTAL lifetime costs of all available options so the best decisions are possible?

For CLL, that approach would also highlight the dire need for more research and clinical trials into ways to reduce the impact of CLL and CLL treatments on our immunity.

NeIl

[virdieblue]

So many issues go into cost/benefit analysis. Make my head spin. Is Ibrutinib a bargain because I am not hospitalized?...

Virginia

[otonal in reply to virdieblue]

It puzzles me that innovations are always said to cost more, even when it means that less time is spent at the hospital.